ZTS - Zoetis Inc.
172.24
0.230 0.134%
Share volume: 2,676,216
Last Updated: Tue 04 Feb 2025 10:00:00 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.24%
PREVIOUS CLOSE
CHG
CHG%
$172.01
0.30
0.00%
View ratios
| Fiscal Date | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | |
| Report Date | 2023-05-04 | 2023-08-08 | 2023-11-02 | 2024-02-13 | 2024-05-02 | 2024-08-06 | 2024-11-04 | |
| Assets | ||||||||
| Total Assets | 13.754 B | 13.749 B | 14.106 B | 14.286 B | 14.348 B | 14.165 B | 14.357 B | |
| Current Assets | 6.269 B | 6.183 B | 6.222 B | 6.343 B | 6.359 B | 6.202 B | 6.282 B | |
| Inventories | 2.563 B | 2.701 B | 2.744 B | 2.564 B | 2.651 B | 2.452 B | 2.416 B | |
| Other Current Assets | 411.000 M | 443.000 M | 467.000 M | 434.000 M | 440.000 M | 467.000 M | 427.000 M | |
| Short Term Investments | 411.000 M | 443.000 M | 467.000 M | 434.000 M | 440.000 M | 0.000 | 0.000 | |
| Total Receivables | 1.186 B | 1.322 B | 1.257 B | 1.304 B | 1.293 B | 0.000 | 0.000 | |
| Current Cash | 2.109 B | 1.717 B | 1.754 B | 2.041 B | 1.975 B | 1.574 B | 1.714 B | |
| Total Non-current Assets | 7.485 B | 7.566 B | 7.884 B | 7.943 B | 7.989 B | 0.000 | 0.000 | |
| Property Plant Equipment | 2.913 B | 3.011 B | 3.092 B | 3.204 B | 3.251 B | 3.200 B | 3.298 B | |
| Other Assets | 143.000 M | 173.000 M | 216.000 M | 206.000 M | 227.000 M | 4.763 B | 4.777 B | |
| Intangible Assets | 1.314 B | 1.252 B | 1.398 B | 1.338 B | 1.295 B | 0.000 | 0.000 | |
| Goodwill | 2.738 B | 2.714 B | 2.762 B | 2.759 B | 2.759 B | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 13.754 B | 13.749 B | 14.106 B | 14.286 B | 14.348 B | 14.165 B | 14.357 B | |
| Total liabilities | 9.260 B | 9.124 B | 9.028 B | 9.289 B | 9.290 B | 9.205 B | 9.123 B | |
| Total current liabilities | 1.915 B | 1.769 B | 1.608 B | 1.889 B | 1.909 B | 1.797 B | 1.702 B | |
| Accounts Payable | 424.000 M | 464.000 M | 388.000 M | 411.000 M | 405.000 M | 420.000 M | 404.000 M | |
| Other liabilities | 478.000 M | 495.000 M | 521.000 M | 508.000 M | 505.000 M | 403.000 M | 401.000 M | |
| Current long term debt | 3.000 M | 2.000 M | 2.000 M | 3.000 M | 24.000 M | 0.000 | 0.000 | |
| Long term debt | 6.559 B | 6.555 B | 6.552 B | 6.564 B | 6.562 B | 6.563 B | 6.574 B | |
| Other liabilities | 478.000 M | 495.000 M | 521.000 M | 508.000 M | 505.000 M | 403.000 M | 401.000 M | |
| Minority interest | -3.000 M | -4.000 M | -4.000 M | -6.000 M | -6.000 M | 0.000 | 0.000 | |
| Total Shareholder equity | 4.494 B | 4.625 B | 5.078 B | 4.997 B | 5.058 B | 4.966 B | 5.234 B | |
| Common stock | 463.500 M | 461.900 M | 460.300 M | 458.988 M | 458.000 M | 1.151 B | 1.168 B | |
| Retained earnings | 9.045 B | 9.543 B | 10.140 B | 10.295 B | 10.696 B | 11.124 B | 11.806 B |